Alnylam Pharmaceuticals | Resultat Før Skat



Pre Tax Profit Lave om Dato
Acadia Pharmaceuticals USD 161.08M 122.28M 2024-12
Agios Pharmaceuticals USD -105399000 1.11B 2024-12
Alnylam Pharmaceuticals USD -193958000 85.3M 2024-12
Amgen USD 3.38B 111M 2024-12
Arrowhead Research USD -175115000 2.32M 2024-12
BioMarin Pharmaceutical USD 169.64M 35.2M 2024-12
Incyte USD 406.83M 147.12M 2024-12
Ionis Pharmaceuticals USD -107000000 37M 2024-12
Moderna USD -1184000000 1.2B 2024-12
Neurocrine Biosciences USD 162.6M 27.7M 2024-12
Novartis USD 4.66B 269M 2024-12
PTC Therapeutics USD -97991000 12.26M 2024-09
Regeneron Pharmaceuticals USD 958.1M 534.9M 2024-12
Sanofi USD 2.32B 2.64B 2024-12
Sarepta Therapeutics USD 171.74M 137.74M 2024-12
Takeda JPY 26.41B 92.96B 2024-12
Tectonic Therapeutic USD -17716000 5.02M 2024-09
Ultragenyx Pharmaceutical USD -133404000 191K 2024-12
Vertex Pharmaceuticals USD 1.32B 109.7M 2024-12
Xencor USD -52626000 6.33M 2024-12



Alnylam Pharmaceuticals Resultat Før Skat - Aktuelle værdier, historiske data, prognoser, statistik, diagrammer og økonomisk kalender - Mar 2025.